Covance Shanghai strengthens safety pharmacology capabilities for in-house IND packages in Asia

Covance Shanghai is pleased to announce an expansion of its general toxicology capabilities to include safety pharmacology studies, allowing our Asia-Pacific clients to more easily complete their IND requirements for CFDA regulations. What are the new safety pharmacology offerings? The general tox team in Shanghai is now capable of running …

Regulatory And Market Access Considerations With Drug Abuse Potential

Designing a comprehensive self-administration drug abuse liability study | Part II

Series Introduction Regulatory agencies require that any drug (parent or major metabolite) that penetrates the brain and has CNS activity, regardless of its therapeutic indication, be assessed for that drug’s abuse potential. In this series on Assessing Potential Drug Abuse, we are sharing how the team at Covance designs and setup accurate and …